Literature DB >> 20029928

Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors.

Heiko Zettl1, Manfred Schubert-Zsilavecz, Dieter Steinhilber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20029928     DOI： 10.1002/cmdc.200900448

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  10 in total

1.  Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in antidiabetic extracts.

Authors:  Laura Guasch; Esther Sala; María José Ojeda; Cristina Valls; Cinta Bladé; Miquel Mulero; Mayte Blay; Anna Ardévol; Santiago Garcia-Vallvé; Gerard Pujadas
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

2.  The efficacy of vildagliptin concomitant with insulin therapy in type 2 diabetic subjects.

Authors:  Daisuke Ito; Kazuyuki Inoue; Kimie Kaneko; Morifumi Yanagisawa; Takashi Sumita; Yuichi Ikegami; Takuya Awata; Hitoshi Ishida; Shigehiro Katayama; Kouichi Inukai
Journal:  J Clin Med Res       Date:  2015-03-01

3.  Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes.

Authors:  Feng-Fei Li; Yun Shen; Rui Sun; Dan-Feng Zhang; Xing Jin; Xiao-Fang Zhai; Mao-Yuan Chen; Xiao-Fei Su; Jin-Dan Wu; Lei Ye; Jian-Hua Ma
Journal:  Diabetes Ther       Date:  2017-09-18       Impact factor: 2.945

4.  Cholinesterase Inhibitory Activities of Adamantyl-Based Derivatives and Their Molecular Docking Studies.

Authors:  Huey Chong Kwong; Siau Hui Mah; Tze Shyang Chia; Ching Kheng Quah; Gin Keat Lim; C S Chidan Kumar
Journal:  Molecules       Date:  2017-06-17       Impact factor: 4.411

5.  Structure⁻Activity Relationship and Molecular Docking of Natural Product Library Reveal Chrysin as a Novel Dipeptidyl Peptidase-4 (DPP-4) Inhibitor: An Integrated In Silico and In Vitro Study.

Authors:  Poonam Kalhotra; Veera C S R Chittepu; Guillermo Osorio-Revilla; Tzayhri Gallardo-Velázquez
Journal:  Molecules       Date:  2018-06-06       Impact factor: 4.411

6.  Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes.

Authors:  Poonam Kalhotra; Veera C S R Chittepu; Guillermo Osorio-Revilla; Tzayhri Gallardo-Velázquez
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

7.  Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19.

Authors:  Shahenda Mahgoub; Samar S Fatahala; Amira I Sayed; Hanaa B Atya; Mohamed F El-Shehry; Hala Afifi; Samir M Awad; Rania H Abd El-Hameed; Heba Taha
Journal:  Bioorg Chem       Date:  2022-08-10       Impact factor: 5.307

8.  Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays.

Authors:  Laura Guasch; Maria José Ojeda; Noemí González-Abuín; Esther Sala; Adrià Cereto-Massagué; Miquel Mulero; Cristina Valls; Montserrat Pinent; Anna Ardévol; Santiago Garcia-Vallvé; Gerard Pujadas
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

9.  Crystal structure and Hirshfeld surface analysis of a pyridiniminium bromide salt: 1-[2-(adamantan-1-yl)-2-oxoeth-yl]pyridin-4-iminium bromide.

Authors:  Huey Chong Kwong; Imdad Mahmud Pathi; C S Chidan Kumar; Ching Kheng Quah; Md Azharul Arafath
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-06-28

10.  Synthesis and Crystallographic Insight into the Structural Aspects of Some Novel Adamantane-Based Ester Derivatives.

Authors:  C S Chidan Kumar; Huey Chong Kwong; Siau Hui Mah; Tze Shyang Chia; Wan-Sin Loh; Ching Kheng Quah; Gin Keat Lim; Siddegowda Chandraju; Hoong-Kun Fun
Journal:  Molecules       Date:  2015-10-16       Impact factor: 4.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.